Clinical
Studies
Breast
Cancer
Cardiology
Colon Cancer
Dermatology
Diabetes
Gastrointestinal
HIV/AIDS
Mental Health
Neurology
Obesity/Weight Management
Women's Health
Other
Special
Features
Advances/Research
Altered Calcium and Vitamin D Metabolism in Premenstrual Dysphoric Disorder
| Principal Investigator: | Susan Thys-Jacobs, M.D. | |
| Time frame of study: | Ongoing | |
| Time frame of participation: | 3 months | |
| Number of participants needed: | 105 | |
| Location of study: | St.
Luke's-Roosevelt Hospital Center Antenucci Research Pavilion 432 W. 58th Street New York, NY 10019 |
|
| Contact Name: | Samantha Oren | |
| Contact Number: | (212) 523-7701 | |
| Contact Email: | soren@chpnet.org |
Summary:
Premenstrual
syndrome is a common condition that occurs in normally menstruating women.
Recent evidence has suggested that PMS may be associated with abnormalities
in calcium hormones. Because bone mass and the prevention of bone loss
depends in part on lifelong calcium intake, PMS may be an important marker
for the development of osteoporosis.
This study looks at
calcium regulating hormones across the menstrual cycle. Participants will
be screened for premenstrual symptoms with a daily self-assessment diary
for approximately 3 months. During the 3rd month, blood drawing
will be performed at 8 time points.
Criteria
for Participation:
Participating
women should meet the following criteria:
• Ages 18-45
• Regular
menstrual cycle (25-35 days)
• History
of moderate to severe PMS (subjects)
- or -
• No
history of moderate to severe PMS (controls)
• Not currently
taking oral contraceptives
• Not pregnant
Benefits
or Compensation:
Participants
will receive the following:
• Free hormone
evaluation
• Compensation